Investigation of the Association Between COVID-19 and Hepatitis B Vaccination Among Healthcare Workers: A Cross-Sectional Study in Turkey
Keywords:
COVID-19, Hepatitis B, vaccine, healthcare workerAbstract
Objectives: Vaccination is a cornerstone of public health. While COVID-19 vaccination became globally prioritized during the pandemic, Hepatitis B immunization remains essential, particularly among healthcare workers (HCWs). This study evaluated Hepatitis B immunization and factors associated with COVID-19 vaccination among Turkish HCWs. Methods: A retrospective cross-sectional study was conducted between February 1 and August 15, 2024, at Mersin City Training and Research Hospital. Employees and trainee students who underwent periodic health examinations were included. Participants were grouped as physicians, non-physician HCWs, and non-healthcare professionals. Data included demographics, vaccination history, hematological and biochemical parameters, and clinical characteristics. Logistic regression identified factors associated with COVID-19 vaccination status. Results: Of 4,048 participants, 92.1% received at least one COVID-19 vaccine dose and 90.0% were vaccinated against Hepatitis B. Physicians demonstrated the highest coverage for both vaccines. Male gender (OR=1.37, 95% CI: 1.04–1.80), non-physician HCW status (OR=2.51, 95% CI: 1.33–4.75), non-healthcare professional status (OR=2.99, 95% CI: 1.55–5.77), and elevated platelet count (OR=1.54, 95% CI: 1.04–2.28) were independently associated with COVID-19 non-vaccination. Hepatitis B immunization history strongly reduced the odds of COVID-19 non-vaccination (OR=0.30, 95% CI: 0.23–0.40) Conclusions: Vaccine uptake varied across occupational groups, with physicians achieving the highest rates. Prior Hepatitis B vaccination was positively associated with COVID-19 vaccine acceptance, emphasizing the role of previous immunization behavior in new vaccine adoption. Tailored strategies are required to reinforce coverage among non-physician HCWs.
References
1. Tanriover MD, et al. Hepatitis B vaccination among internal medicine residents in Turkey: 90.5% cover-age. J Hosp Infect. 2017;95(3):265–268.
2. WHO. Global hepatitis report 2022. Geneva: World Health Organization; 2022.
3. Atasoy H, et al. COVID-19 vaccination acceptance among Turkish HCWs: qualitative examination. Int J Nurs Terminol Knowledge. 2022;33(4):136–146.
4. Pereira da Silva A, et al. COVID-19 vaccination acceptance and hesitancy in healthcare workers and the general population: a systematic review. Int J Environ Res Public Health. 2024;21(9):1134.
5. Vaccination barriers among Turkish HCWs during H1N1 and influenza pandemics. Turk J Med Sci. 2016;46(5):1580–1588.
6. Maltezou HC, Poland GA. Immunization of healthcare personnel. Curr Infect Dis Rep. 2014;16(10):366.
7. Dube E, et al. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763–1773.
8. Ogunleye OO, et al. Determinants of Hepatitis B vaccination in HCWs in Nigeria. Hum Vaccin Immunother. 2021;17(5):1629–1636.
9. Salali GD, Uysal MS. COVID-19 vaccine acceptance in Turkey: 66%. Public Health Nurs. 2023;40(2):87–94.
10. Cengiz B, et al. COVID-19 vaccination rates in Turkish cities by education/income. Vaccines. 2022;10(11):1933.
11. Syme MR, et al. COVID-19 vaccination mandates and HCW uptake. Vaccine. 2024;42(7):1128–1135.
12. Poland GA. COVID-19 vaccine uptake trends. Lancet Infect Dis. 2021;21(5):642–644.
13. Atik Biswas S, et al. HCWs attitudes in Turkey during COVID-19. J Hosp Infect. 2021;114:109–116.
14. Schmid P, Rauber D, Betsch C. Barriers to HCW vaccination. Vaccine. 2017;35(44):5907–5916.
15. Papagiannis D, et al. Hepatitis B in Greek HCW students: 81.4% coverage. BMC Public Health. 2016;16:1056.
16. Gray R, et al. Nursing students' HepB knowledge & attitudes in Greece. Int J Environ Res Public Health. 2024;21(1):PMC11587404.
17. Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccine uptake. Vaccine. 2015;33(34):4219–4225.
18. Larson HJ, et al. Vaccine hesitancy: Definition and determinants. Vaccine. 2015;33(34):4161–4164.
19. Qunaibi E, et al. COVID-19 hesitancy in HCWs. Int J Infect Dis. 2021;107:215–221.
20. Murphy J, et al. Psychological characteristics of vaccine hesitancy. Psychol Med. 2021;51(10):1898–1909.
21. Kwok KO, et al. HCW vaccine attitudes and trust. Vaccine. 2021;39(9):1278–1284.
22. World Health Organization. Interim recommendations for use of the inactivated COVID-19 vaccine, Coro-naVac [Internet]. Geneva: WHO; 2021 [cited 2025 Jun 20]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-Sinovac-CoronaVac-2021.1
23. European Medicines Agency. Comirnaty COVID-19 vaccine: EU summary of product characteristics [In-ternet]. 2021 [cited 2025 Jun 20]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty
24. Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C–based equations to estimate GFR without race. N Engl J Med. 2021;385:1737–1749.
25. Karafillakis E, et al. HCWs as messengers for vaccination. Lancet. 2016;388(10060):795–795.
26. Gagneux-Brunon A, et al. Hesitancy among French nurses (23%). Clin Microbiol Infect. 2021;27(4):602.e9–602.e15.
27. Tomljenovic N, et al. Comparative hesitancy in Croatian nurses. Vaccine. 2021;39(15):2196–2205.
28. Poland GA, Jacobson RM. Understanding vaccine hesitancy and refusal. Clin Infect Dis. 2019;45(12):1437–1442.
29. Sridharan M, Sahu R. Platelets as inflammatory biomarkers in systemic disorders: A review. Inflammo-pharmacology. 2021;29(2):413–428.
30. Boekholdt SM, et al. Inflammatory markers and increased risk of thrombosis. Eur Heart J. 2004;25(11):952–960.
31. Yuen CYS, Tarrant M. Determinants of COVID-19 vaccine hesitancy in healthcare workers: A systematic review. Vaccine. 2020;38(49):7580–7591.
Downloads
Section
License
All Journal's articles are Open Access papers distributed under the terms of the Creative Commons Attribution License CC BY-NC 4.0 Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reproductions with commercial intent will require written permission and payment of royalties.